✦ LIBER ✦

Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy

✍ Scribed by Marianna Colagrande; Mauro Di Ianni; Gino Coletti; Ketty Peris; Maria Concetta Fargnoli; Lorenzo Moretti; Mario Lapecorella; Antonio Tabilio

Publisher: Carden Jennings Publishing
Year: 2008
Tongue: English
Weight: 249 KB
Volume: 89
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-008-0220-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ciprofloxacin-Induced Toxic Epidermal Ne

Ciprofloxacin-Induced Toxic Epidermal Necrolysis in a Patient with Systemic Lupus Erythematosus

✍ M. Jongen-Lavrencic; P.M. Schneeberger; J.G. Hoeven 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 182 KB

Strontium ranelate-induced toxic epiderm

Strontium ranelate-induced toxic epidermal necrolysis in a patient with post-menopausal osteoporosis

✍ H. Y. Lee; D. Lie; K. S. Lim; T. Thirumoorthy; S. M. Pang 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 105 KB

Pulmonary embolism in a patient with mul

Pulmonary embolism in a patient with multiple myeloma receiving thalidomide–dexamethasone therapy

✍ Wen-Juei Jeng; Ming-Chung Kuo; Lee-Yung Shih; Pao-Hsien Chu 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 276 KB

Toxic epidermal necrolysis (TEN) associa

Toxic epidermal necrolysis (TEN) associated with herbal medication use in a patient with systemic lupus erythematosus

✍ Vagish Hemmige; Erin Jenkins; Jhee Un Lee; Vineet M. Arora 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

Antitumour necrosis factor-α antibodies

Antitumour necrosis factor-α antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis

✍ M. Fischer ; E. Fiedler ; W.C. Marsch ; J. Wohlrab 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

Improved survival in red blood cell tran

Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy

✍ Heather A. Leitch; Jocelyn M. Chase; Trisha A. Goodman; Hatoon Ezzat; Meaghan D. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

## Abstract Many patients with primary myelofibrosis (PMF) become red blood cell (RBC) transfusion dependent (TD), risking iron overload (IOL). Iron chelation therapy (ICT) may decrease the risk of haemosiderosis associated organ dysfunction, though its benefit in PMF is undefined. To assess the ef